CompoAtlas

NasoGel Spray

Natural health product licensed in Canada

Licence holder
NeilMed Pharmaceuticals Inc.
NPN or DIN-HM
80027141
Status
Active licence
Licence date
30 August 2011
Revision date
2 February 2026
Form
Vaporisateur
Route of administration
Nasale
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Glycérine, Allantoïne, Propylène glycol, Bicarbonate de sodium, Aloe Barbadensis Leaf Extract., Eau purifiée, Chlorure de benzalkonium, Hyaluronate de sodium

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 3 yearsminimum: 1 Pulvérisateur ; maximum: 2 Pulvérisateurminimum: 4 Tous les jours ; maximum: 6 Tous les jours
AdultesNot specifiedminimum: 2 Pulvérisateur ; maximum: 4 Pulvérisateurminimum: 4 Tous les jours ; maximum: 6 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Moisturizes and hydrates to help relieve symptoms of dry nasal passages.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80027141

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line